PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 51 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $149,000 | +39.3% | 32,443 | 0.0% | 0.00% | – |
| Q1 2020 | $107,000 | -60.1% | 32,443 | -26.0% | 0.00% | – |
| Q4 2019 | $268,000 | +63.4% | 43,843 | +11.4% | 0.00% | – |
| Q3 2019 | $164,000 | -69.0% | 39,343 | -2.5% | 0.00% | -100.0% |
| Q2 2019 | $529,000 | +75.2% | 40,343 | +26.9% | 0.00% | – |
| Q1 2019 | $302,000 | +214.6% | 31,788 | +1.9% | 0.00% | – |
| Q4 2018 | $96,000 | – | 31,188 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,607,044 | $4,194,000 | 0.48% |
| NEA Management Company, LLC | 6,643,704 | $17,340,000 | 0.35% |
| Platform Technology Partners | 251,723 | $657,000 | 0.29% |
| DAFNA Capital Management LLC | 378,611 | $988,000 | 0.25% |
| Avidity Partners Management LP | 4,405,000 | $11,497,000 | 0.24% |
| Endurant Capital Management LP | 360,078 | $940,000 | 0.23% |
| Rock Springs Capital Management LP | 2,581,299 | $6,737,000 | 0.16% |
| RA Capital Management | 2,850,000 | $7,439,000 | 0.13% |
| New Legacy Group, LLC | 240,575 | $628,000 | 0.12% |
| XTX Topco Ltd | 15,574 | $41,000 | 0.02% |